Strategem Capital Corporation
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 45,000 | -56,000 | 87,000 | 81,000 | 120,000 | -- |
| Operating Revenue | 45,000 | -56,000 | 87,000 | 81,000 | 120,000 | -- |
| Cost Of Revenue | 7,000 | 4,000 | 4,000 | 5,000 | 3,000 | -- |
| Gross Profit | 38,000 | -60,000 | 83,000 | 76,000 | 117,000 | -- |
| Selling General And Administration | 67,000 | 180,000 | 69,000 | 48,000 | 60,000 | -- |
| General And Administrative Expense | 67,000 | 180,000 | 69,000 | 48,000 | 60,000 | -- |
| Other Operating Expenses | -583,000 | -1.1M | 679,000 | 50,000 | 65,000 | -- |
| Operating Expense | -516,000 | -931,000 | 748,000 | 98,000 | 125,000 | -- |
| Operating Income | 554,000 | 871,000 | -665,000 | -22,000 | -8,000 | -- |
| EBIT | 563,000 | 846,000 | -665,000 | 8,000 | -14,000 | -- |
| Interest Expense | 0.00 | 0.00 | 0.00 | 5,000 | 11,000 | -- |
| Interest Expense Non Operating | 0.00 | 0.00 | 0.00 | 5,000 | 11,000 | -- |
| Net Interest Income | 0.00 | 0.00 | 0.00 | -5,000 | -11,000 | -- |
| Other Income Expense | 9,000 | -25,000 | -- | 30,000 | -6,000 | 4,000 |
| Gain On Sale Of Security | 9,000 | -25,000 | -- | 30,000 | -6,000 | 4,000 |
| Pretax Income | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Tax Effect Of Unusual Items | 1,350 | -3,750 | 0.00 | 4,500 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Net Income From Continuing Operation Net Minority Interest | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Net Income Including Noncontrolling Interests | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Net Income Common Stockholders | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Net Income | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| EBITDA | 563,000 | 846,000 | -665,000 | 8,000 | -14,000 | -- |
| Normalized EBITDA | 554,000 | 871,000 | -665,000 | -22,000 | -8,000 | -- |
| Basic EPS | 0.06 | 0.09 | -0.07 | -- | 0.00 | -0.07 |
| Diluted EPS | 0.06 | 0.09 | -0.07 | -- | 0.00 | -0.07 |
| Basic Average Shares | 9.1M | 9.1M | 9.1M | -- | 9.2M | 9.2M |
| Diluted Average Shares | 9.1M | 9.1M | 9.1M | -- | 9.2M | 9.2M |
| Total Unusual Items | 9,000 | -25,000 | -- | 30,000 | -6,000 | 4,000 |
| Total Unusual Items Excluding Goodwill | 9,000 | -25,000 | -- | 30,000 | -6,000 | 4,000 |
| Tax Rate For Calcs | 0.15 | 0.15 | 0.00 | 0.15 | 0.00 | -- |
| Normalized Income | 555,350 | 867,250 | -665,000 | -22,500 | -19,000 | -- |
| Diluted NI Availto Com Stockholders | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Net Income Continuous Operations | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Net Non Operating Interest Income Expense | 0.00 | 0.00 | 0.00 | -5,000 | -11,000 | -- |
| Other Gand A | 67,000 | 130,000 | 69,000 | 48,000 | 60,000 | -- |
| Reconciled Cost Of Revenue | 7,000 | 4,000 | 4,000 | 5,000 | 3,000 | -- |
| Salaries And Wages | 0.00 | 50,000 | 0.00 | 0.00 | 0.00 | -- |
| Total Expenses | -509,000 | -927,000 | 752,000 | 103,000 | 128,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 835,000 | 487,000 | 579,000 | 695,000 | 0.00 | -- |
| Cash Cash Equivalents And Short Term Investments | 11.2M | 10.6M | 9.8M | 10.4M | 10.9M | -- |
| Other Short Term Investments | 10.3M | 10.1M | 9.2M | 9.7M | 10.9M | -- |
| Current Assets | 11.2M | 10.6M | 9.8M | 10.4M | 10.9M | -- |
| Total Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Assets | 11.2M | 10.6M | 9.8M | 10.4M | 10.9M | -- |
| Current Debt | -- | -- | -- | -- | 503,000 | 616,000 |
| Current Debt And Capital Lease Obligation | -- | -- | -- | -- | 503,000 | 616,000 |
| Accounts Payable | 17,000 | 17,000 | 33,000 | 30,000 | 19,000 | -- |
| Payables | 42,000 | 32,000 | 37,000 | 31,000 | 19,000 | -- |
| Payables And Accrued Expenses | 42,000 | 32,000 | 37,000 | 31,000 | 19,000 | -- |
| Current Liabilities | 42,000 | 32,000 | 37,000 | 31,000 | 522,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 42,000 | 32,000 | 37,000 | 31,000 | 522,000 | -- |
| Common Stock | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | -- |
| Capital Stock | 11.5M | 11.5M | 11.5M | 11.5M | 11.5M | -- |
| Retained Earnings | -337,000 | -900,000 | -1.7M | -1.1M | -1.1M | -- |
| Common Stock Equity | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Stockholders Equity | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Total Equity Gross Minority Interest | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Total Capitalization | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Net Tangible Assets | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Tangible Book Value | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Working Capital | 11.1M | 10.6M | 9.7M | 10.4M | 10.4M | -- |
| Invested Capital | 11.1M | 10.6M | 9.7M | 10.4M | 10.9M | -- |
| Total Debt | -- | -- | -- | -- | 503,000 | 616,000 |
| Net Debt | -- | -- | -- | -- | 503,000 | 616,000 |
| Share Issued | 9.1M | 9.1M | 9.1M | 9.1M | 9.2M | -- |
| Ordinary Shares Number | 9.1M | 9.1M | 9.1M | 9.1M | 9.2M | -- |
| Dueto Related Parties Current | 25,000 | 15,000 | 4,000 | 1,000 | 0.00 | -- |
| Line Of Credit | -- | -- | -- | -- | 503,000 | 616,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 348,000 | -92,000 | -116,000 | 1.2M | 129,000 | -- |
| Cash Flow From Continuing Operating Activities | 348,000 | -92,000 | -116,000 | 1.2M | 129,000 | -- |
| Change In Working Capital | 10,000 | -5,000 | 6,000 | 12,000 | -2,000 | -- |
| Change In Payables And Accrued Expense | 10,000 | -5,000 | 6,000 | 12,000 | -2,000 | -- |
| Change In Payable | 10,000 | -5,000 | 6,000 | -- | -2,000 | -7,000 |
| Other Non Cash Items | 359,000 | 42,000 | -106,000 | 1.2M | 102,000 | -- |
| Repurchase Of Capital Stock | 0.00 | 0.00 | 0.00 | -16,000 | -16,000 | -- |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | -16,000 | -16,000 | -- |
| Common Stock Payments | 0.00 | 0.00 | 0.00 | -16,000 | -16,000 | -- |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | -16,000 | -16,000 | -- |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | 0.00 | -16,000 | -16,000 | -- |
| Changes In Cash | 348,000 | -92,000 | -116,000 | 1.2M | 113,000 | -- |
| Beginning Cash Position | 487,000 | 579,000 | 695,000 | -503,000 | -616,000 | -- |
| End Cash Position | 835,000 | 487,000 | 579,000 | 695,000 | -503,000 | -- |
| Free Cash Flow | 348,000 | -92,000 | -116,000 | 1.2M | 129,000 | -- |
| Change In Account Payable | 0.00 | -16,000 | 3,000 | 11,000 | 2,000 | -- |
| Gain Loss On Investment Securities | 11,000 | 112,000 | -28,000 | -14,000 | -13,000 | -- |
| Net Foreign Currency Exchange Gain Loss | -9,000 | 25,000 | 0.00 | -32,000 | 6,000 | -- |
| Net Income From Continuing Operations | 563,000 | 846,000 | -665,000 | 3,000 | -25,000 | -- |
| Operating Gains Losses | 2,000 | 137,000 | -28,000 | -46,000 | -7,000 | -- |
| Unrealized Gain Loss On Investment Securities | -586,000 | -1.1M | 677,000 | 40,000 | 61,000 | -- |